SIM
ELDN icon

Spark Investment Management’s Eledon Pharmaceuticals ELDN Stock Holding History

Spark Investment Management’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-219
Closed -$54K – 803
2016
Q3 		$54K Buy
+219
New +$80.1K ﹤0.01% 781
2014
Q4 		– Sell
-64
Closed -$155K – 723
2014
Q3 		$155K Buy
+64
New +$182K 0.02% 543

Other funds holding ELDN

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Spark Investment Management's ELDN Position: Q4 2016 in Review

Spark Investment Management sold out of Eledon Pharmaceuticals (ELDN) in Q4 2016, closing a stake of 219 shares — an estimated $54K sold.

Spark Investment Management first reported a position in ELDN in Q3 2014 and held it in 2 quarters. The position peaked at $155K in Q3 2014. 42 funds tracked by Wall St. Rank hold ELDN as of Q4 2016.

  • Spark Investment Management reported no remaining Eledon Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Spark Investment Management sold 219 Eledon Pharmaceuticals shares in Q4 2016, an estimated $54K.
  • Spark Investment Management first reported a position in Eledon Pharmaceuticals in Q3 2014 and held it in 2 quarters.
  • Spark Investment Management's Eledon Pharmaceuticals position peaked at $155K in Q3 2014.
  • 42 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q4 2016.

Based on Spark Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.